Concentrations of pro- and anti-apoptotic proteins, as well as calcium ions in mitochondria of endometrioid adenocarcinoma cells depending on the degree of its differentiation
https://doi.org/10.17709/2410-1893-2025-12-2-3
EDN: EAAXMO
Abstract
Purpose of the study. To study the concentration of calcium ions, pro- and antiapoptotic proteins (cytochrome C, AIF-1, and Bcl-2) in the mitochondria of endometrioid adenocarcinoma (EA) cells in oncogynecological patients, depending on the degree of differentiation of malignant cells.
Patients and methods. The study included patients who had undergone surgical treatment for endometrial adenocarcinoma (n = 42) and uterine fibroids (n = 14). The patients with endometrial adenocarcinoma were further classified as having highly differentiated (G1) disease, moderately differentiated (G2) disease, or poorly differentiated (G3) disease. The average age of patients with endometrial adenocarcinoma was 60.8 ± 2.9 years, and the average age of patients with fibroids was 49.4 ± 2.5 years. It is noteworthy that the patients in this study did not receive any neoadjuvant treatment. The concentration of cytochrome C (ng/mg protein), AIF (pg/mg protein), Bcl-2 (pg/mg protein), and calcium (mM/mg protein) was determined in the mitochondria of EA, fibroids, and intact uterus cells by ELISA. The statistical analysis of the results was performed using the Statistica 10.0 software package.
Results. A decline in the degree of tumor cell differentiation was accompanied by a decrease in calcium levels within the mitochondria, with G2 and G3 exhibiting an average reduction of 2.0 times compared to the intact uterus. Furthermore, the Bcl-2 content in the tumor mitochondria at G3 demonstrated an average increase of 1.9 times compared to G1 and G2 (p < 0.05). Furthermore, the cytochrome C level at G1 was found to be 2.2 times higher than at G2 and 1.9 times higher (p < 0.05) than at G3. In the mitochondria of cells with G3 differentiation, the highest AIF-1 values were observed, which were 2.1 times higher than in intact cells and 1.9 times higher (p < 0.05) compared to the values in the mitochondria of myoma cells.
Conclusions. It is hypothesized that the process of apoptosis is suppressed in the mitochondria of endometrioid adenocarcinoma cells due to an accumulation of Bcl-2 and a decrease in calcium. This accumulation of Bcl-2 and decrease in calcium activates energy processes, leading to the accumulation of cytochrome C and AIF-1. The severity of the biochemical events identified in the mitochondria of endometrioid adenocarcinoma increases with the degree of malignancy of the tumor cells. This increase in severity appears to contribute to an escalation in the aggressiveness of the tumor.
About the Authors
E. M. FrantsiyantsNational Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Elena M. Frantsiyants – Dr. Sci. (Biology), Professor, Deputy General Director for Science, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: http://orcid.org/0000-0003-3618-6890 eLibrary SPIN: 9427-9928, AuthorID: 462868 Scopus Author ID: 55890047700 Web of Science ResearcherID: Y-1491-2018
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
I. V. Kaplieva
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Irina V. Kaplieva – Dr. Sci. (Medicine), Head of the Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-3972-2452 eLibrary SPIN: 5047-1541, AuthorID: 734116 Scopus Author ID: 23994000800 Web of Science ResearcherID: AAE-3540-2019
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
I. V. Neskubina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Irina V. Neskubina – Dr. Sci. (Biology), Senior Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-7395-3086 eLibrary SPIN: 3581-8531, Author ID: 794688 Scopus Author ID: 6507509066 Web of Science ResearcherID: AAG-8731-2019
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
Yu. А. Petrova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Yulia А. Petrova – Cand. Sci. (Biology), Senior Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: http://orcid.org/0000-0002-2674-9832 eLibrary SPIN: 2168-8737, AuthorID: 558241 Scopus Author ID: 37026863400 Web of Science ResearcherID: AAE-4168-2022
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
A. P. Menshenina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Anna P. Menshenina – Dr. Sci. (Medicine), Associate Professor, Leading Researcher at the Department of Oncogynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: http://orcid.org/0000-0002-7968-5078 eLibrary SPIN: 6845-4794, AuthorID: 715810 Scopus Author ID: 57191983118
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
L. K. Trepitaki
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Lidia K. Trepitaki – Cand. Sci. (Biology), Researcher at the Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-9749-2747 eLibrary SPIN: 2052-1248, AuthorID: 734359 Scopus Author ID: 55357624700 Researcher ID: AAG-9218-2019
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
N. S. Lesovaya
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Natalia S. Lesovaya – Junior Researcher at the Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0001-5686-8659 eLibrary SPIN: 6995-9917, AuthorID: 706102 Scopus Author ID: 57218210795
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
V. A. Bandovkina
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Valerija A. Bandovkina – Dr. Sci. (Biology), Leading Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: http://orcid.org/0000-0002-2302-8271 eLibrary SPIN: 8806-2641, Author ID: 696989 Scopus Author ID: 57194276288 Web of Science ResearcherID: AAG-8708-2019
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
E. I. Surikova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Ekaterina I. Surikova – Cand. Sci. (Biology), Senior Researcher at Laboratory of Malignant Tumor Pathogenesis Study, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-4318-7587 eLibrary SPIN: 2401-4115, AuthorID: 301537 Scopus Author ID: 6507092816 Web of Science ResearcherID: AAG-8748-2019
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
M. L. Adamyan
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Meri L. Adamyan – Cand. Sci. (Medicine), researcher, Department of Oncogynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0003-4188-3746 eLibrary SPIN: 9929-3414, AuthorID: 710702 Scopus Author ID: 58579808700
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
O. E. Zhenilo
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Oksana E. Zhenilo – Cand. Sci. (Medicine), researcher, Department of Oncogynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
M. A. Rogozin
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Mark A. Rogozin – graduate student, Section of Reproductive Tumors, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
A. O. Adamyan
Rostov State Medical University
Rostov-on-Don, Russian Federation
Alla O. Adamyan – student, Rostov State Medical University, Rostov-on-Don, Russian Federation
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
E. A. Ozerkova
National Medical Research Centre for Oncology
Rostov-on-Don, Russian Federation
Elena A. Ozerkova – oncologist of the clinical diagnostic Department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
A. A. Vereskunova
Rostov State Medical University
Rostov-on-Don, Russian Federation
Aleksandra A. Vereskunova – student, Rostov State Medical University, Rostov-on-Don, Russian Federation
Competing Interests:
The author declares that there are no obvious and potential conflicts of interest related to the publication of this article.
References
1. Kit OI, Frantsiyants EM, Bandovkina VA, Moiseenko TI, Chernikova NV, Adamyan ML, et al. Modifying effect of obesity on the content of sex hormones and their receptors in endometrial adenocarcinoma and its surrounding tissue. Cardiometry. 2022;2:34–40. https://doi.org/10.18137/cardiometry.2022.21.3440
2. Filippova SYu, Mezhevova IV, Chembarova TV, Novikova IA, Verenikina EV, Zhenilo OE, et al. Experience in creating primary cultures of endometrial cancer and studying cells carrying phenotype of cancer stem cells. South Russian Journal of Cancer.. 2024;5(3):16–30. https://doi.org/10.37748/2686-9039-2024-5-3-2 EDN: EYIRUH
3. Drocaş I, Crăiţoiu Ş, Stepan AE, Drocaş IA, Stepan MD. Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas. Curr Health Sci J. 2022 Apr-Jun;48(2):187–195.
4. Kit OI, Kovalenko NV, Maksimov AYu, Verenikina EV. Bioinformational and clinical aspects of identificationof differentially expressed genes by tumor cells in endometrialcarcinoma and rare forms of uterine body cancer. Medical News of North Caucasus. 2023;18(1):37–41. (In Russ.). https://doi.org/10.14300/mnnc.2023.18009
5. Mang C, Birkenmaier A, Cathomas G, Humburg J. Endometrioid endometrial adenocarcinoma: an increase of G3 cancers? Arch Gynecol Obstet. 2017 Jun;295(6):1435–1440. https://doi.org/10.1007/s00404-017-4370-4
6. Krishna Kumar K, Upadhyaya K, Cn RT. Bcl-2 May Contribute to Evolution of Endometrial Hyperplasia, but It Isn't a Factor in Subsequent Carcinogenesis. Arch Razi Inst. 2024 Aug 1;79(4):827–832. https://doi.org/10.32592/ari.2024.79.4.827
7. Singh P, Lim B. Targeting Apoptosis in Cancer. Curr Oncol Rep. 2022 Mar;24(3):273–284. https://doi.org/10.1007/s11912-022-01199-y
8. Sterea AM, El Hiani Y. The Role of Mitochondrial Calcium Signaling in the Pathophysiology of Cancer Cells. Adv Exp Med Biol. 2020;1131:747–770. https://doi.org/10.1007/978-3-030-12457-1_30
9. Winter JM, Yadav T, Rutter J. Stressed to death: Mitochondrial stress responses connect respiration and apoptosis in cancer. Mol Cell. 2022 Sep 15;82(18):3321–3332. https://doi.org/10.1016/j.molcel.2022.07.012
10. Glover HL, Schreiner A, Dewson G, Tait SWG. Mitochondria and cell death. Nat Cell Biol. 2024 Sep;26(9):1434–1446. https://doi.org/10.1038/s41556-024-01429-4
11. Castillo Ferrer C, Berthenet K, Ichim G. Apoptosis - Fueling the oncogenic fire. FEBS J. 2021 Aug;288(15):4445–4463. https://doi.org/10.1111/febs.15624
12. Zhao F, Chen DY, Jing B, Jiang Y, Liu LY, Song H. Effect of Flammulina velutipes polysaccharide on mitochondrial apoptosis in lung adenocarcinoma A549 cells. Sci Rep. 2024 Jul 12;14(1):16102. https://doi.org/10.1038/s41598-024-57211-x
13. Kit OI, Frantsiyants EM, Ilchenko SA, Bandovkina VA, Neskubina IV, Shikhlyarova AI, et al. Mitochondrial apoptosis factors in colorectal cancer tissueResearch and Practical Medicine Journal. 2025;12(1):26–39. (In Russ.). https://doi.org/10.17709/2410-1893-2025-12-1-2
14. Kit OI, Frantsiyants EM, Ilchenko SA, Bandovkina VA, Neskubina IV, Petrova YuA. Characteristics of mitochondrial cytochrome C distribution in patients with colorectal cancer]. Ulyanovsk Medico-Biological Journal. 2024;4:112–121. (In Russ.). https://doi.org/10.34014/2227-1848-2024-4-112-121
15. Egorova MV, Afanasyev SA. Isolation of mitochondria from cells and tissues of animals and human: modern methodical approaches. Siberian Medical Journal. 2011;26(1–1):22–28. (In Russ.).
16. Gureev AP, Kokina AV, Syromyatnikov MYu, Popov VN. Optimization of methods for the mitochondria isolation from different mice tissues. Proceedings of Voronezh State University. Series: Chemistry. Biology. Pharmacy2015;4:6165. (In Russ.).
17. Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P. et al. Various Aspects of Calcium Signaling in the Regulation of Apoptosis, Autophagy, Cell Proliferation, and Cancer. Int J Mol Sci. 2020 Nov 6;21(21):8323. https://doi.org/10.3390/ijms21218323
18. Shoshan-Barmatz V, Arif T, Shteinfer-Kuzmine A. Apoptotic proteins with non-apoptotic activity: expression and function in cancer. Apoptosis. 2023 Jun;28(5-6):730–753. https://doi.org/10.1007/s10495-023-01835-3
19. Frantsiyants EM, Neskubina IV, Surikova EI, Shikhlyarova AI, Kaplieva IV, Nemashkalova LA, Trepitaki LK. The state of apoptosis factor system in mitochondria of skin and tumor cells in standard and stimulated growth of B16/F10 melanoma in female C57BL/6 mice. Research and Practical Medicine Journal. 2021;8(1):8–19. (In Russ.). https://doi.org/10.17709/2409-2231-2021-8-1-1
20. Dodokhova MA, Safronenko AV, Kotieva IM, Milaeva ER, Shpakovsky DB, Trepel VG, et al. Mitochondrial dysfunction as a mechanism of antitumor and antimetastatic action of hybrid organotin compounds. Problems of Biological, Medical and Pharmaceutical Chemistry. 2021;24(11):28–33. (In Russ.). https://doi.org/10.29296/25877313-2021-11-05
Review
For citations:
Frantsiyants E.M., Kaplieva I.V., Neskubina I.V., Petrova Yu.А., Menshenina A.P., Trepitaki L.K., Lesovaya N.S., Bandovkina V.A., Surikova E.I., Adamyan M.L., Zhenilo O.E., Rogozin M.A., Adamyan A.O., Ozerkova E.A., Vereskunova A.A. Concentrations of pro- and anti-apoptotic proteins, as well as calcium ions in mitochondria of endometrioid adenocarcinoma cells depending on the degree of its differentiation. Research and Practical Medicine Journal. 2025;12(2):35-45. (In Russ.) https://doi.org/10.17709/2410-1893-2025-12-2-3. EDN: EAAXMO